Company News »

Marrone Bio Innovations Receives Stay of Trading Suspension Pending NASDAQ Hearing

Business Wire
Share on StockTwits
Published on

Marrone Bio Innovations, Inc. (the “Company”) (NASDAQ:MBII) today announced that it has received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) indicating that a NASDAQ Hearings Panel (the “Panel”) granted the Company’s request to extend the stay of any suspension in trading in the Company’s common stock on NASDAQ at least pending the completion of the Company’s scheduled hearing before the Panel and a final determination regarding the Company’s listing status. As previously announced, as part of the Company’s request for a hearing before the Panel, the Company requested the extended stay of any suspension in trading. Also as previously announced, the hearing is scheduled for June 18, 2015. Although the Panel typically issues decisions within 30 days of the hearing date, there is no requirement that the Panel do so within that time frame.

At the hearing, the Company plans to present a definitive plan to regain compliance with the NASDAQ listing rule that requires the Company to be current in the filing of its periodic financial reports with the Securities and Exchange Commission and to request an extension of time to file its delayed reports. The Panel has the discretion to grant the Company an extension to do so through November 2, 2015.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this release may constitute “forward-looking statements and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this release include those regarding the Company’s submission of a plan to regain compliance with NASDAQ listing rules, the hearing process and any further extension of the stay on delisting. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond its control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include uncertainty surrounding management’s evaluation of the nature and scope of any necessary restatement to its previously filed financial statements, potential legal or regulatory action related to the matters under investigation and adverse decisions by the SEC or NASDAQ. Additional information that could lead to material changes in the Company’s performance is contained in its filings with the SEC.

Share on StockTwits